Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Research Study Looking at the Effect of Timing of Meal After Dosing and Water Volume at Dosing on How the Medicine Zenagamtide is Taken up by the Body of Participants With Overweight or Obesity
Sponsor: Novo Nordisk A/S
Summary
The purpose of this clinical study is to test how taking zenagamtide tablets with different meal/water variations affects how much zenagamtide enters the bloodstream in people who have overweight or obesity. All participants will get zenagamtide.
Official title: Investigating the Effect of Post-dose Meal Timings and Water Volume at Dosing on the Pharmacokinetic Properties of Oral Zenagamtide in Participants With Overweight or Obesity
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
320
Start Date
2026-09-07
Completion Date
2028-06-12
Last Updated
2026-09-11
Healthy Volunteers
No
Conditions
Interventions
Zenagamtide injection
Zenagamtide will be administered to one of the body parts: thigh, abdomen or upper arm
Zenagamtide tablet
Zenagamtide tablet will be taken in the morning in fasted state.
Locations (1)
Charité - Campus Charité Mitte - Charité Research Organisation GmbH
Berlin, Germany